Safety of Quadrivalent Human Papillomavirus Vaccine Administered Routinely to Females DermatologistsBlog.com: Author Interview: Nicola Klein, MD, PhD, co-director and research scientist at the Kaiser Permanente Vaccine Study Center in Oakland, Calif. DermatologistsBlog.com: What are the main findings of the study? This study of almost 200,000 females who received nearly 350,000 doses of the quadrivalent human [...]
HPV Vaccine helpful in some Cervical & Vulvar Disease: Interview
Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data. Author Interview: Elmar A. Joura, MD Associate Professor of Gynecology Medical University of Vienna, AKH Department of Obstetrics and Gynecology Comprehensive Cancer Center Vienna (CCC) What are the main findings of the study? Prophylactic vaccination with quadrivalent HPV vaccine is highly efficacious in preventing cervical intraepithelial neoplasia, adenocarcinoma in situ, vulvar intraepithelial [...]
http://dermatologistsblog.com/infections/hpv-vaccine-helpful-in-some-cervical-vulvar-disease-interview/
Two doses of HPV vaccine may be as protective as full course
Two doses of the human papillomavirus (HPV) vaccine Cervarix were as effective as the current standard three-dose regimen after four years of follow-up, according to researchers from the National Cancer Institute (NCI), part of the National Institutes of Health, and their colleagues. The results of the study, based on data from a community-based clinical trial [...]
http://dermatologistsblog.com/infections/hpv-2/two-doses-of-hpv-vaccine-may-be-as-protective-as-full-course/
Screening for HPV persistence and cervical cancer risk
Women over the age of thirty who test positive for HPV (Human Papillomavirus) should be re-tested two years later as part of cervical cancer screening, according to a study published online TK in the Journal of the National Cancer Institute. HPV infection is the main cause of cervical cancer, although most women infected with HPV [...]
http://dermatologistsblog.com/infections/screening-for-hpv-persistence-and-cervical-cancer-risk/
Some cutaneous HPV types may be involved in non-melanoma skin cancer development
Non-melanoma skin cancer is the most common form of malignancy in adult Caucasian populations, with more than a million cases recorded each year in the USA alone. Lifestyle risk factors… but The incidence of these cancers is continuously rising due mainly to the aging structure of Western populations, and as a result of growing prosperity, [...]
http://dermatologistsblog.com/skin-cancer/some-cutaneous-hpv-types-may-be-involved-in-non-melanoma-skin-cancer-development/
New protein-based inhibitor could provide topical treatment for HPV
BOSTON (April 26, 2011) —Human papillomavirus (HPV) causes cervical cancer, the second most common cause of cancer death for women, and is a common cause of anogenital and some head and neck cancers. Thanks to research being done at Tufts University School of Medicine, patients infected with cancer-causing HPV may someday have an alternative to [...]
http://dermatologistsblog.com/infections/hpv-2/new-protein-based-inhibitor-could-provide-topical-treatment-for-hpv/
Lung cancer and HPV antibodies
ORLANDO, Fla. — Researchers with the International Agency for Research on Cancer (IARC) have found that people with lung cancer were significantly more likely to have several high-risk forms of human papillomavirus (HPV) antibodies compared to those who did not have lung cancer. These results, which were presented at the AACR 102nd Annual Meeting 2011, [...]
http://dermatologistsblog.com/infections/hpv-2/lung-cancer-and-hpv-antibodies/



